Sage Laboratories Inc
—- Market cap
- —
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: Sage Laboratories Inc stock price vs CPB: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CPB's multiple
Needs EPS (TTM).
Implied fair value · at Sage Laboratories Inc's multiple
Needs Sage Laboratories Inc P/E.
Engine logicSage Laboratories Incvalued onCPB’smultiple
Metric by metric
Snapshot Sep 4, 4:00 PM ET
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: Sage Laboratories Inc Latest annual filing · CPB FY 2025 (ended Aug 3, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 48% equity / 52% debt · EV / Revenue 1.28x · EV / EBITDA 6.54x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
SAGE LABORATORIES INC · implied price per share
Reporting currency could not be verified.
CAMPBELL'S Co · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Sage Laboratories Inc · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
—
1.76x
Net debt / EBITDA
Leverage against operating earnings
—
3.36x
Cash and equivalents
Liquid reserves on the balance sheet
—
$132.00M
Total debt
Interest-bearing obligations outstanding
—
$6.86B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
COCA COLA CO
Sage Laboratories Inc vs KO
PEPSICO INC
Sage Laboratories Inc vs PEP
Keysight Technologies, Inc.
Sage Laboratories Inc vs KEYS
Mondelez International, Inc.
Sage Laboratories Inc vs MDLZ
J M SMUCKER Co
Sage Laboratories Inc vs SJM
Lamb Weston Holdings, Inc.
Sage Laboratories Inc vs LW
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.